ThromboGenics' Commitment to the US Retina Community Highlighted at American Association of Ophthalmology 2014 Meeting Oct 14, 2014 11:50AM
Cynapsus Therapeutics Announces Hiring of New Chief Scientific Officer and EVP, CMC Oct 7, 2014 04:00PM
3PEA International Launches its PaySign ® Brand of Prepaid Cards Oct 2, 2014 09:07AM
ThromboGenics' JETREA(R) Gains Approval in South Korea Sep 8, 2014 01:54AM
ThromboGenics Business Update H1 2014 Aug 28, 2014 11:56AM


Aug 28, 2014 01:37AM Nicox first half 2014 financial results
Apr 9, 2014 06:34AM Novartis AG (NVS) Novartis Names New Division Leaders for Sandoz, Alcon
Dec 18, 2013 02:12PM Perrigo (PRGO) Names CEO Papa as Chairman; Announces Director Slate
Nov 22, 2013 07:05AM Novartis (NVS) Announces $5B Buyback Plan; Updates on Long-Term Expectations
Jan 18, 2013 07:43AM Novartis' (NVS) Alcon Receives Positive CHMP Opinion for Jetrea as VMT Treatment
Mar 16, 2012 07:04AM Novartis' (NVS) Unit Gets Exclusive Rights to Ocriplasmin Outside the U.S.
Oct 25, 2011 08:20AM Novartis (NVS) Misses Q3 EPS by 6c, Sales Miss Expectations, Offers Q4 Outlook
Sep 13, 2011 06:44AM Novartis (NVS) Updates on Long-Term Strategy; Comments on Plans for Alcon